🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2019-07-01
Trial ID
NCT05942768
Treatments Being Tested
Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Status
Recruiting
Location
the First Affiliated Hospital of Zhengzhou University
Start Date
2025-06-01
Trial ID
NCT06896422
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This is a single arm, open-label, non-randomized and single-center phase II...
Status
Unknown
Location
Li Xu
Start Date
2020-08-01
Trial ID
NCT04454905
Treatments Being Tested
This is a Phase II clinical trial for Decitabine plus Camrelizumab resistan...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2020-02-02
Trial ID
NCT04233294
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of cryoa...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2020-07-07
Trial ID
NCT04299581
Treatments Being Tested
This open-label, randomized, two-arm, phase 2 study has the primary objecti...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2020-08-01
Trial ID
NCT04514081
Treatments Being Tested